Bender James G. 4
4 · ImmunoCellular Therapeutics, Ltd. · Filed Mar 11, 2013
Insider Transaction Report
Form 4
Bender James G.
VP, Product Development & Mfg.
Transactions
- Award
Stock Option (right to buy)
2013-03-07−80,000→ 80,000 totalExercise: $2.72Exp: 2020-02-29→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over four years beginning March 1, 2013.